,2,3 The triple-negative breast cancer (TNBC) subtype represents a particularly aggressive form, characterized by the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2) expression.4 Here, ERBB2 is linked to triple-negative breast carcinoma.